D
Dyne Therapeutics, Inc. DYN
$10.05 $0.202.03% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -412.89M -367.13M -317.42M -294.51M -257.60M
Total Depreciation and Amortization 1.89M 1.79M 1.67M 1.62M 1.62M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 40.30M 35.88M 42.87M 38.73M 35.53M
Change in Net Operating Assets 11.13M 9.74M -19.49M 11.12M 1.44M
Cash from Operations -359.56M -319.73M -292.37M -243.04M -219.01M
Capital Expenditure -2.37M -3.17M -2.38M -1.38M -1.30M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -24.81M -19.62M -201.70M -160.49M -128.35M
Cash from Investing -27.18M -22.78M -204.08M -161.87M -129.65M
Total Debt Issued 98.80M -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 164.86M 542.75M 809.90M 806.41M 788.85M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 263.66M 542.75M 809.90M 806.41M 788.85M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -123.08M 200.24M 313.45M 401.50M 440.19M